Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Centre Hospitalier St Anne

97 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen nextUnknown journal · 2026-06-28Unmixing the Psychedelic Connectome: Brain Network Traits of PsilocybinNetwork Neuroscience · 2026-06-13Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic ActionCurrent Psychiatry Reports · 2026-06-04Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-05-12Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratusFrontiers in Behavioral Neuroscience · 2026-05-06356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSDClinicalTrials.gov · 2026-03-08Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intakeJournal of Analytical Toxicology · 2026-02-18Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brainScientific Reports · 2026-02-13Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinMolecular Psychiatry · 2026-02-02No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of painNature Communications · 2026-01-21Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-08Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyBMJ Supportive & Palliative Care · 2025-11-02Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)ClinicalTrials.gov · 2025-10-06Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyHealthcare · 2025-09-11Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental modelsFrontiers in Systems Neuroscience · 2025-08-04Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe MetabolomeChemBioChem · 2025-05-02Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische AnwendungNervenheilkunde · 2025-04-30Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic PainJournal of Pain · 2025-03-31Oregon’s Emerging Psilocybin Services Workforce: An Environmental ScanDrug and Alcohol Dependence · 2025-01-31Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31Psilocybin increases emotional empathy in patients with major depressionMolecular Psychiatry · 2024-12-17Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implicationsTrends in Anaesthesia and Critical Care · 2024-11-30Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey studyJournal of Affective Disorders · 2024-10-21What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative studyPalliative & Supportive Care · 2024-09-30Psilocybin increases optimistic engagement over time: computational modelling of behaviour in ratsTranslational Psychiatry · 2024-09-29A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-18Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapyScientific Reports · 2024-07-16Developing Core Consensus Measures for Assessment of Psilocybin ServicesDrug and Alcohol Dependence · 2024-06-30Psilocybin and 2C-B at Encoding Distort Episodic FamiliarityBiological Psychiatry Cognitive Neuroscience and Neuroimaging · 2024-06-25Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-AACS Chemical Neuroscience · 2024-06-24Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi studyJournal of Psychopharmacology · 2024-06-17Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanismsMolecular Psychiatry · 2024-04-26Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female ratsNeuroscience Applied · 2023-12-31Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigsNeuroscience Applied · 2023-12-31Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06Peak Experiences: Lessons Learned from a Feasibility Study of Psilocybin-assisted Therapy for Demoralization in Patients Receiving Hospice CareJournal of the Academy of Consultation-Liaison Psychiatry · 2023-10-31Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled studyBrain Behavior and Immunity · 2023-09-06Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memoriesPsychopharmacology · 2023-06-01Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic modelPsychological Medicine · 2023-06-01Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participantsNeuropsychopharmacology · 2023-05-24How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of changeJournal of Affective Disorders · 2023-05-02Psychedelische Therapie mit Psilocybin und Psychotherapie - Wo stehen wir?PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · 2023-02-28Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2022-12-31Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controlsNeuroscience Applied · 2022-12-31Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatednessJournal of Psychopharmacology · 2022-12-31Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27Psilocybin: a revolution in psychedelic medicines in the US?BMJ · 2022-10-05Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych Open · 2022-09-05[The use of psilocybin for treatment-resistant depression].Unknown journal · 2022-08-31Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-17The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-08-07Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.Frontiers in Psychiatry · 2022-07-06Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug Testing and Analysis · 2022-05-28Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.The International Journal of Neuropsychopharmacology · 2022-03-31Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology · 2022-02-24Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.Translational Psychiatry · 2022-02-22Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjectsNeuroscience Applied · 2021-12-31Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.Clinical Pharmacology & Therapeutics · 2021-11-21Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.Frontiers in Psychiatry · 2021-06-28Spontaneous and deliberate creative cognition during and after psilocybin exposure.Translational Psychiatry · 2021-04-07P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental studyEuropean Neuropsychopharmacology · 2021-02-24Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory micebioRxiv · 2021-02-16A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.International Journal of Molecular Sciences · 2021-01-14Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pigEuropean Neuropsychopharmacology · 2020-12-03[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]Unknown journal · 2020-11-11P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brainEuropean Neuropsychopharmacology · 2020-10-31Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybinNeuropsychopharmacology · 2020-05-22P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective stateEuropean Neuropsychopharmacology · 2020-01-27P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low dosesEuropean Neuropsychopharmacology · 2019-11-30Replication and extension of a model predicting response to psilocybinPsychopharmacology · 2019-06-14Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific Reports · 2017-10-12The Effects of LSD and Psilocin on Anxiety-Related Behaviours in ZebrafishStudent Research Proceedings · 2017-05-14[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].Unknown journal · 2016-10-05Psychedelics not linked to mental health problems or suicidal behavior: a population study.Journal of Psychopharmacology · 2015-03-04Psychedelics and mental health: a population study.PLoS ONE · 2013-08-18Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata.Unknown journal · 1997-12-31Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis.Unknown journal · 1997-06-30

Author directory

Carhart-Harris RL.58 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ49 publicationsJohnson MW44 publicationsErritzoe D42 publicationsRoseman L41 publicationsRobin Carhart-Harris39 publicationsBarrett FS.34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsHendricks PS27 publicationsDavid Erritzøe25 publicationsRoland R. Griffiths25 publicationsGarcia-Romeu A23 publicationsDavid Nutt22 publicationsFranz X. Vollenweider22 publicationsGitte M. Knudsen22 publicationsPáleníček T.22 publicationsRosenblat JD22 publicationsFisher PM21 publicationsDavis AK20 publicationsDea Siggaard Stenbæk19 publicationsKargbo RB.19 publicationsKatrin H. Preller19 publicationsMcIntyre RS.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDos Santos RG18 publicationsLiechti ME18 publicationsPatrick M. Fisher18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsDirk Hoffmeister17 publicationsHusain MI17 publicationsKuypers KPC.17 publicationsM. Madsen17 publicationsMatthew W. Johnson17 publicationsSimonsson O17 publicationsTomáš Páleníček17 publicationsKringelbach ML.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsBrice Ozenne15 publicationsFischer R.15 publicationsFrederick S. Barrett15 publicationsGonzález-Maeso J15 publicationsGuy M. Goodwin15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsKwan AC.15 publicationsMadsen MK15 publicationsMason NL.15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsYale University15 publicationsAlbert Garcia-Romeu14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKometer M14 publicationsNayak SM14 publicationsBasel13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsManish Agrawal13 publicationsNathan D. Sepeda13 publicationsSandeep M. Nayak13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJames Rucker12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMcCulloch DE12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsJoshua Woolley11 publicationsKaelen M11 publicationsMartin Kuchař11 publicationsMuhammad Ishrat Husain11 publicationsNichols CD.11 publicationsOsika W11 publicationsScott T. Aaronson11 publicationsStephen Ross11 publicationsWang X.11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsDavoudian PA10 publicationsErica Kaczmarek10 publicationsHoráček J10 publicationsHouman Farzin10 publicationsKovar KA.10 publicationsMatthias E. Liechti10 publicationsMichael P. Bogenschutz10 publicationsRoger S. McIntyre10 publicationsSchmid Y10 publicationsSchoevers RA10 publicationsUniversity of California10 publicationsVohryzek J10 publicationsZoe Doyle10 publicationsAaronson ST9 publicationsAndrea Mattarei9 publicationsArmand S9 publicationsBotvinnik A9 publications